Shopping Cart 0
Cart Subtotal
USD 0

Courtagen Life Sciences Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company's products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equipments and mitochondrial panels. It also provides drug development services such as target discovery, validation, clinical development, clinical trials, decentralized test development, pre-clinical and clinical trial protocol and companion diagnostic services. Courtagen's products are used in treatment of mitochondrial disorders, epilepsy and seizure disorders, and neuro-developmental disorders. The company serves patients and physicians. It operates in the US and Bermuda. Courtagen is headquartered in Woburn, Massachusetts, the US.

Courtagen Life Sciences Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11

Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 11

Courtagen Life Sciences Secures USD8 Million In Series B Venture Financing 12

Partnerships 12

Courtagen Life Sciences Enters into Agreement with Astellas Pharma 12

Courtagen Life Sciences Enters into Agreement with Connecticut Children's Medical Center 13

Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 14

Courtagen Life Sciences Enters Into Co-Development Agreement With Avaxia Biologics To Evaluate Oral Antibody For Radiation Damage 15

Acquisition 15

Courtagen Life Sciences Acquires Medicinal Genomics 15

Courtagen Life Sciences Inc-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Strategy And Business Planning 20

Feb 17, 2017: Courtagen Launches New Avantra Genetics Division to Provide Personalized Genetic Information for Functional Medicine 20

Corporate Communications 21

Jan 21, 2016: Courtagen Life Sciences Receives New York State Clinical Laboratory Approval 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22


List Of Figure

List of Figures

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Courtagen Life Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11

Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 11

Courtagen Life Sciences Secures USD8 Million In Series B Venture Financing 12

Courtagen Life Sciences Enters into Agreement with Astellas Pharma 12

Courtagen Life Sciences Enters into Agreement with Connecticut Children's Medical Center 13

Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 14

Courtagen Life Sciences Enters Into Co-Development Agreement With Avaxia Biologics To Evaluate Oral Antibody For Radiation Damage 15

Courtagen Life Sciences Acquires Medicinal Genomics 15

Courtagen Life Sciences Inc, Key Competitors 17

Courtagen Life Sciences Inc, Key Employees 18

Courtagen Life Sciences Inc, Subsidiaries 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Courtagen Life Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company's products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equipments and mitochondrial panels. It also provides drug development services such as target discovery, validation, clinical development, clinical trials, decentralized test development, pre-clinical and clinical trial protocol and companion diagnostic services. Courtagen's products are used in treatment of mitochondrial disorders, epilepsy and seizure disorders, and neuro-developmental disorders. The company serves patients and physicians. It operates in the US and Bermuda. Courtagen is headquartered in Woburn, Massachusetts, the US.

Courtagen Life Sciences Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11

Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 11

Courtagen Life Sciences Secures USD8 Million In Series B Venture Financing 12

Partnerships 12

Courtagen Life Sciences Enters into Agreement with Astellas Pharma 12

Courtagen Life Sciences Enters into Agreement with Connecticut Children's Medical Center 13

Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 14

Courtagen Life Sciences Enters Into Co-Development Agreement With Avaxia Biologics To Evaluate Oral Antibody For Radiation Damage 15

Acquisition 15

Courtagen Life Sciences Acquires Medicinal Genomics 15

Courtagen Life Sciences Inc-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Strategy And Business Planning 20

Feb 17, 2017: Courtagen Launches New Avantra Genetics Division to Provide Personalized Genetic Information for Functional Medicine 20

Corporate Communications 21

Jan 21, 2016: Courtagen Life Sciences Receives New York State Clinical Laboratory Approval 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22


List Of Figure

List of Figures

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 1

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Courtagen Life Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9

Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11

Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 11

Courtagen Life Sciences Secures USD8 Million In Series B Venture Financing 12

Courtagen Life Sciences Enters into Agreement with Astellas Pharma 12

Courtagen Life Sciences Enters into Agreement with Connecticut Children's Medical Center 13

Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 14

Courtagen Life Sciences Enters Into Co-Development Agreement With Avaxia Biologics To Evaluate Oral Antibody For Radiation Damage 15

Courtagen Life Sciences Acquires Medicinal Genomics 15

Courtagen Life Sciences Inc, Key Competitors 17

Courtagen Life Sciences Inc, Key Employees 18

Courtagen Life Sciences Inc, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Courtagen Life Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.